China and India are the leading exporters of Dexmedetomidine hydrochloride, accounting for the majority of global supply, while the United States, Germany, and Japan represent the largest importers by value. These importing countries consistently absorb over 60% of total reported shipments, reflecting established demand in advanced healthcare markets. Recent trade data shows stable export volumes from China alongside modest growth in Indian exports, while Dexmedetomidine hydrochloride prices have remained relatively flat across major trading corridors amid steady regulatory approvals and manufacturing capacity utilization.
Dexmedetomidine hydrochloride is a white to off-white crystalline powder, odorless and hygroscopic, with a melting point of approximately 191–193 °C (decomposes). It is a synthetic organic compound classified as an imidazole derivative and a selective α₂-adrenoceptor agonist. Primarily used as the active pharmaceutical ingredient (API) in sedative and analgesic formulations, it serves no significant role as a chemical intermediate in industrial synthesis. Its commercial applications are confined exclusively to human pharmaceuticals—specifically intravenous sedation in intensive care and procedural settings—and it has no established use in agrochemicals, dyes, polymers, coatings, or solvents.
This chemical is included in Fine Chemicals - Pharmaceutical Intermediates & APIs. See more about what is Dexmedetomidine hydrochloride and Dexmedetomidine hydrochloride SDS information.
Find Dexmedetomidine hydrochloride supply and Dexmedetomidine hydrochloride suppliers on Guidechem to meet your sourcing needs from 185 trusted and certifedsuppliers.
Guidechem assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, fitness for purpose or timeliness.